Journal article
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
Abstract
Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation for patients hospitalized for COVID-19 infection. More recently, multiple clinical trials and larger observational studies have provided evidence for …
Authors
Barnes GD; Burnett A; Allen A; Ansell J; Blumenstein M; Clark NP; Crowther M; Dager WE; Deitelzweig SB; Ellsworth S
Journal
Journal of Thrombosis and Thrombolysis, Vol. 54, No. 2, pp. 197–210
Publisher
Springer Nature
Publication Date
August 2022
DOI
10.1007/s11239-022-02643-3
ISSN
0929-5305